12th Annual Florey Postgraduate Conference

Activity: Other

Description

Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Poster Presentation
Adelaide, South Australia
Period25 Sept 2018